Get the tools used by (smart)2 investors.

Upside (Analyst Target) for Alkem Laboratories Ltd

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

539523: Alkem Laboratories Ltd

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and inter...

4,823.85 INR
Price
INR
Fair Value
Upside
4,409.90 - 6,440.00
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Alkem Laboratories Ltd's Upside (Analyst Target):

Mar 2016Mar 2018Mar 2020Mar 2022Mar 20245.0%10.0%15.0%20.0%25.0%

Performance Summary
  • Alkem Laboratories's latest twelve months upside (analyst target) is 14.8%
  • Alkem Laboratories's upside (analyst target) decreased in 2022 (13.9%, -30.9%) and 2023 (3.9%, -72.0%) and increased in 2024 (10.5%, +169.2%).

How does Alkem Laboratories Ltd BO's Upside (Analyst Target) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Alkem Laboratories Ltd because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Upside (Analyst Target)

Hide this widget
analyst_target_upside
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Upside (Analyst Target) in the predictions category include:

  • EPV Fair Value Upside - Our estimate of fair value upside for a company using earnings power value method.
  • Fair Value Label - Fair Value label assigned based on the percentage upside when compared to internal fair value estimate. Value is one of UNAVAILABLE, BARGAIN, UNDERVALUED, FAIR, OVERVALUED, or EXPENSIVE
  • Predicted EV / LTM Revenue - Our estimate of the fair value EV / LTM Revenue for a company.
  • Number of No Opinion Recommendations - The number of analysts publishing a No Opinion recommendation for the stock.
View Full List

Search for metric or datapoint

Upside (Analyst Target)

The percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price.

Definition of Upside (Analyst Target)

Hide this widget

Upside (Analyst Target) is the percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price. Downside (Analyst Target) is the inverse of this metric.


    Upside = (Analyst Price Target / Stock Price) - 1

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-19.2%180.8%383.9%2060100140

The chart above depicts the distribution of upside (analyst target) for companies operating in the Healthcare sector in the Developing economic region. Over 490 companies were considered in this analysis, and 478 had meaningful values. The average upside (analyst target) of companies in the sector is 32.4% with a standard deviation of 40.9%.

Alkem Laboratories Ltd's Upside (Analyst Target) of 14.8% ranks in the 29.6% percentile for the sector. The following table provides additional summary stats:

Upside (Analyst Target) In The Healthcare Sector
Economic Risk RegionDeveloping
Total Constituents498
Included Constituents478
Min-28.6%
Max377.3%
Median24.9%
Mean32.4%
Standard Deviation40.9%

You can find companies with similar upside (analyst target) using this stock screener.

All rights reserved. Terms Of Use